Edwards Lifesciences | EW - Interest Expense On Debt

Stock Price
81.05
Daily Change
-0.21 -0.26%
Monthly
-4.96%
Yearly
11.06%
Q2 Forecast
78.61

Edwards Lifesciences reported $38.6M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Abbott USD 42M 2M Dec/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.33M 17K Sep/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Boston Scientific USD 90M 3M Dec/2025
Cooper Companies USD 22.4M 2M Dec/2025
Dexcom USD 4.7M 0 Sep/2025
Edwards Lifesciences USD 38.6M 1.2M Sep/2025
Globus Medical USD 17K 5.1B Dec/2025
Hologic USD 27.6M 1000K Dec/2025
ICU Medical USD 20.64M 21.39M Dec/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 9.2M 2.2M Dec/2025
Integra LifeSciences USD 23.67M 953K Dec/2025
Intuitive Surgical USD 19.35B 811.4M Sep/2025
J&J USD 18M 290M Sep/2025
Masimo USD 7.5M 1.3M Dec/2025
Medtronic USD 181M 0 Dec/2025
Merit Medical Systems USD 6.36M 390K Dec/2025
Stryker USD 157M 46.17B Sep/2025
Tandem Diabetes Care USD 2.07M 872.58M Dec/2025
Teleflex USD 28.15M 3.69M Dec/2025
Zimmer Biomet Holdings USD 71.9M 3.5M Dec/2025